 | • レポートコード：D005-08269 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ヒト絨毛性ゴナドトロピン（HCG）の世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒト絨毛性ゴナドトロピン（HCG）の種類別市場規模（天然源抽出、組換えDNAテクノロジー）、用途別市場規模（女性不妊治療、オリゴスペルミック治療、停留精巣治療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：EMD Serono, Inc、Kamiya Biomedical Company、Bristol Myers Squibb Company、Ferring B.V、Leebio、Merck & Co., Inc、Cigna、Scrippslabs、Fresenius Kabi AG, LLC、Sanzyme ・地域別グローバル市場分析 2015年-2020年 ・ヒト絨毛性ゴナドトロピン（HCG）の北米市場（アメリカ、カナダ、メキシコ） ・ヒト絨毛性ゴナドトロピン（HCG）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒト絨毛性ゴナドトロピン（HCG）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒト絨毛性ゴナドトロピン（HCG）の南米市場（ブラジル、アルゼンチン） ・ヒト絨毛性ゴナドトロピン（HCG）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：天然源抽出、組換えDNAテクノロジー ・用途別分析：女性不妊治療、オリゴスペルミック治療、停留精巣治療、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Human Chorionic Gonadotropin (HCG) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.7% in the forecast period of 2020 to 2025 and will expected to reach USD 472.2 million by 2025, from USD 377.7 million in 2019.
The Human Chorionic Gonadotropin (HCG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Human Chorionic Gonadotropin (HCG) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Human Chorionic Gonadotropin (HCG) market has been segmented into
Natural Source Extraction
Recombinant DNA Technology
By Application, Human Chorionic Gonadotropin (HCG) has been segmented into:
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Chorionic Gonadotropin (HCG) market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Chorionic Gonadotropin (HCG) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Chorionic Gonadotropin (HCG) market.
The report offers in-depth assessment of the growth and other aspects of the Human Chorionic Gonadotropin (HCG) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Human Chorionic Gonadotropin (HCG) Market Share Analysis
Human Chorionic Gonadotropin (HCG) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Chorionic Gonadotropin (HCG) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Chorionic Gonadotropin (HCG) sales, revenue and market share for each player covered in this report.
The major players covered in Human Chorionic Gonadotropin (HCG) are:
EMD Serono, Inc
Kamiya Biomedical Company
Bristol Myers Squibb Company
Ferring B.V
Leebio
Merck & Co., Inc
Cigna
Scrippslabs
Fresenius Kabi AG, LLC
Sanzyme
Among other players domestic and global, Human Chorionic Gonadotropin (HCG) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Chorionic Gonadotropin (HCG) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Chorionic Gonadotropin (HCG), with price, sales, revenue and global market share of Human Chorionic Gonadotropin (HCG) in 2018 and 2019.
Chapter 3, the Human Chorionic Gonadotropin (HCG) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Chorionic Gonadotropin (HCG) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human Chorionic Gonadotropin (HCG) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human Chorionic Gonadotropin (HCG) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Human Chorionic Gonadotropin (HCG) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Chorionic Gonadotropin (HCG) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Natural Source Extraction
1.2.3 Recombinant DNA Technology
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Chorionic Gonadotropin (HCG) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Female Infertility Treatment
1.3.3 Oligospermic Treatment
1.3.4 Cryptorchidism Treatment
1.3.5 Others
1.4 Overview of Global Human Chorionic Gonadotropin (HCG) Market
1.4.1 Global Human Chorionic Gonadotropin (HCG) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 EMD Serono, Inc
2.1.1 EMD Serono, Inc Details
2.1.2 EMD Serono, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 EMD Serono, Inc SWOT Analysis
2.1.4 EMD Serono, Inc Product and Services
2.1.5 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kamiya Biomedical Company
2.2.1 Kamiya Biomedical Company Details
2.2.2 Kamiya Biomedical Company Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kamiya Biomedical Company SWOT Analysis
2.2.4 Kamiya Biomedical Company Product and Services
2.2.5 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol Myers Squibb Company
2.3.1 Bristol Myers Squibb Company Details
2.3.2 Bristol Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol Myers Squibb Company SWOT Analysis
2.3.4 Bristol Myers Squibb Company Product and Services
2.3.5 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ferring B.V
2.4.1 Ferring B.V Details
2.4.2 Ferring B.V Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ferring B.V SWOT Analysis
2.4.4 Ferring B.V Product and Services
2.4.5 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Leebio
2.5.1 Leebio Details
2.5.2 Leebio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Leebio SWOT Analysis
2.5.4 Leebio Product and Services
2.5.5 Leebio Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck & Co., Inc
2.6.1 Merck & Co., Inc Details
2.6.2 Merck & Co., Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck & Co., Inc SWOT Analysis
2.6.4 Merck & Co., Inc Product and Services
2.6.5 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cigna
2.7.1 Cigna Details
2.7.2 Cigna Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cigna SWOT Analysis
2.7.4 Cigna Product and Services
2.7.5 Cigna Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Scrippslabs
2.8.1 Scrippslabs Details
2.8.2 Scrippslabs Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Scrippslabs SWOT Analysis
2.8.4 Scrippslabs Product and Services
2.8.5 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Fresenius Kabi AG, LLC
2.9.1 Fresenius Kabi AG, LLC Details
2.9.2 Fresenius Kabi AG, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Fresenius Kabi AG, LLC SWOT Analysis
2.9.4 Fresenius Kabi AG, LLC Product and Services
2.9.5 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanzyme
2.10.1 Sanzyme Details
2.10.2 Sanzyme Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanzyme SWOT Analysis
2.10.4 Sanzyme Product and Services
2.10.5 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Chorionic Gonadotropin (HCG) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Chorionic Gonadotropin (HCG) Manufacturer Market Share in 2019
3.3.2 Top 6 Human Chorionic Gonadotropin (HCG) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Regions
4.1.1 Global Human Chorionic Gonadotropin (HCG) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
4.3 Europe Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
4.5 South America Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Country
5.1.1 North America Human Chorionic Gonadotropin (HCG) Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Country (2015-2020)
5.2 United States Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
5.3 Canada Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
5.4 Mexico Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Country
6.1.1 Europe Human Chorionic Gonadotropin (HCG) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
6.3 UK Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
6.4 France Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
6.5 Russia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
6.6 Italy Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Regions (2015-2020)
7.2 China Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
7.3 Japan Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
7.4 Korea Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
7.5 India Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
7.7 Australia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Country
8.1.1 South America Human Chorionic Gonadotropin (HCG) Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
8.3 Argentina Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
9.3 Turkey Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
9.4 Egypt Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
9.5 South Africa Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Chorionic Gonadotropin (HCG) Sales and Market Share by Type (2015-2020)
10.2 Global Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Type (2015-2020)
10.3 Global Human Chorionic Gonadotropin (HCG) Price by Type (2015-2020)
11 Global Human Chorionic Gonadotropin (HCG) Market Segment by Application
11.1 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2015-2020)
11.2 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2015-2020)
11.3 Global Human Chorionic Gonadotropin (HCG) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Chorionic Gonadotropin (HCG) Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Chorionic Gonadotropin (HCG) Market Forecast by Regions (2021-2025)
12.2.1 North America Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025)
12.2.2 Europe Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025)
12.2.4 South America Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025)
12.3 Human Chorionic Gonadotropin (HCG) Market Forecast by Type (2021-2025)
12.3.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Type (2021-2025)
12.3.2 Global Human Chorionic Gonadotropin (HCG) Market Share Forecast by Type (2021-2025)
12.4 Human Chorionic Gonadotropin (HCG) Market Forecast by Application (2021-2025)
12.4.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Application (2021-2025)
12.4.2 Global Human Chorionic Gonadotropin (HCG) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Human Chorionic Gonadotropin (HCG) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Chorionic Gonadotropin (HCG) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Chorionic Gonadotropin (HCG) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. EMD Serono, Inc Basic Information, Manufacturing Base and Competitors
Table 8. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Major Business
Table 9. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 10. EMD Serono, Inc SWOT Analysis
Table 11. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product and Services
Table 12. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Kamiya Biomedical Company Basic Information, Manufacturing Base and Competitors
Table 14. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Major Business
Table 15. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 16. Kamiya Biomedical Company SWOT Analysis
Table 17. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product and Services
Table 18. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bristol Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 20. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Major Business
Table 21. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 22. Bristol Myers Squibb Company SWOT Analysis
Table 23. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product and Services
Table 24. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Ferring B.V Basic Information, Manufacturing Base and Competitors
Table 26. Ferring B.V Human Chorionic Gonadotropin (HCG) Major Business
Table 27. Ferring B.V Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 28. Ferring B.V SWOT Analysis
Table 29. Ferring B.V Human Chorionic Gonadotropin (HCG) Product and Services
Table 30. Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Leebio Basic Information, Manufacturing Base and Competitors
Table 32. Leebio Human Chorionic Gonadotropin (HCG) Major Business
Table 33. Leebio Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 34. Leebio SWOT Analysis
Table 35. Leebio Human Chorionic Gonadotropin (HCG) Product and Services
Table 36. Leebio Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 38. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Major Business
Table 39. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 40. Merck & Co., Inc SWOT Analysis
Table 41. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product and Services
Table 42. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Cigna Basic Information, Manufacturing Base and Competitors
Table 44. Cigna Human Chorionic Gonadotropin (HCG) Major Business
Table 45. Cigna Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 46. Cigna SWOT Analysis
Table 47. Cigna Human Chorionic Gonadotropin (HCG) Product and Services
Table 48. Cigna Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Scrippslabs Basic Information, Manufacturing Base and Competitors
Table 50. Scrippslabs Human Chorionic Gonadotropin (HCG) Major Business
Table 51. Scrippslabs Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 52. Scrippslabs SWOT Analysis
Table 53. Scrippslabs Human Chorionic Gonadotropin (HCG) Product and Services
Table 54. Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Fresenius Kabi AG, LLC Basic Information, Manufacturing Base and Competitors
Table 56. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Major Business
Table 57. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 58. Fresenius Kabi AG, LLC SWOT Analysis
Table 59. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product and Services
Table 60. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sanzyme Basic Information, Manufacturing Base and Competitors
Table 62. Sanzyme Human Chorionic Gonadotropin (HCG) Major Business
Table 63. Sanzyme Human Chorionic Gonadotropin (HCG) Total Revenue (USD Million) (2017-2018)
Table 64. Sanzyme SWOT Analysis
Table 65. Sanzyme Human Chorionic Gonadotropin (HCG) Product and Services
Table 66. Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Human Chorionic Gonadotropin (HCG) Sales by Regions (2015-2020) (K Units)
Table 70. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Regions (2015-2020)
Table 71. Global Human Chorionic Gonadotropin (HCG) Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Human Chorionic Gonadotropin (HCG) Sales by Countries (2015-2020) (K Units)
Table 73. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2015-2020)
Table 74. North America Human Chorionic Gonadotropin (HCG) Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2015-2020)
Table 76. Europe Human Chorionic Gonadotropin (HCG) Sales by Countries (2015-2020) (K Units)
Table 77. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2015-2020)
Table 78. Europe Human Chorionic Gonadotropin (HCG) Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Human Chorionic Gonadotropin (HCG) Sales by Countries (2015-2020) (K Units)
Table 83. South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2015-2020)
Table 84. South America Human Chorionic Gonadotropin (HCG) Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2015-2020)
Table 90. Global Human Chorionic Gonadotropin (HCG) Sales by Type (2015-2020) (K Units)
Table 91. Global Human Chorionic Gonadotropin (HCG) Sales Share by Type (2015-2020)
Table 92. Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2015-2020) (USD Million)
Table 93. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Type (2015-2020)
Table 94. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2015-2020) (K Units)
Table 95. Global Human Chorionic Gonadotropin (HCG) Sales Share by Application (2015-2020)
Table 96. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Human Chorionic Gonadotropin (HCG) Market Share Forecast by Regions (2021-2025)
Table 98. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Human Chorionic Gonadotropin (HCG) Market Share Forecast by Type (2021-2025)
Table 100. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Application (2021-2025)
Table 101. Global Human Chorionic Gonadotropin (HCG) Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Human Chorionic Gonadotropin (HCG) Picture
Figure 2. Global Sales Market Share of Human Chorionic Gonadotropin (HCG) by Type in 2019
Figure 3. Natural Source Extraction Picture
Figure 4. Recombinant DNA Technology Picture
Figure 5. Human Chorionic Gonadotropin (HCG) Sales Market Share by Application in 2018
Figure 6. Female Infertility Treatment Picture
Figure 7. Oligospermic Treatment Picture
Figure 8. Cryptorchidism Treatment Picture
Figure 9. Others Picture
Figure 10. Global Human Chorionic Gonadotropin (HCG) Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Human Chorionic Gonadotropin (HCG) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturer in 2019
Figure 31. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Human Chorionic Gonadotropin (HCG) Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Human Chorionic Gonadotropin (HCG) Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions (2015-2020)
Figure 38. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions in 2018
Figure 39. North America Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
Figure 40. Europe Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
Figure 42. South America Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020)
Figure 44. North America Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2015-2020)
Figure 46. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries in 2018
Figure 47. North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries in 2018
Figure 49. United States Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries in 2019
Figure 55. Germany Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions 2019
Figure 63. China Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries in 2019
Figure 70. South America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries in 2019
Figure 71. Brazil Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Human Chorionic Gonadotropin (HCG) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Human Chorionic Gonadotropin (HCG) Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
柔毛膜性生殖腺刺激ホルモンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chronic Gonadotropin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chronic Gonadotropin mar…- 組換えヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant Huma…
- ヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Endostatin market repo…
- ヒト血清アルブミンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Serum Albumin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Serum Albumin marke…
- ヒト用予防ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Prophylactic Human Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prophylactic Human…